Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression

J Leukoc Biol. 2006 Jun;79(6):1286-94. doi: 10.1189/jlb.1205742. Epub 2006 Apr 19.

Abstract

In human monocyte-derived dendritic cells (DC), infection with Mycobacterium tuberculosis and viruses or stimulation with Toll-like receptor type 3 and 4 agonists causes the release of type I interferon (IFN). Here, we describe that the IFN-beta released upon stimulation with lipopolysaccharide (LPS) or polyinosinic:polycytidylic acid (poly I:C) is responsible for a rapid and sustained signal transducer and activator of transcription 1 and 2 activation and expression of IFN-stimulated genes, such as the transcription factor IFN regulatory factor 7 and the chemokine CXC chemokine ligand 10. The autocrine production of IFN-beta from LPS and poly I:C-matured DC (mDC) induced a temporary saturation of the response to type I IFN and a marked decline in the level of the two IFN receptor (IFNAR) subunits. It is interesting that we found that upon clearing of the released cytokines, LPS-stimulated DC reacquired full responsiveness to IFN-beta but only partial responsiveness to IFN-alpha, and their maturation process was unaffected. Monitoring of surface and total levels of the receptor subunits showed that maximal expression of IFNAR2 resumed within 24 h of clearing, and IFNAR1 expression remained low. Thus, mDC can modulate their sensitivity to two IFN subtypes through a differential regulation of the IFNAR subunits.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Cells, Cultured / drug effects
  • Cells, Cultured / metabolism
  • Chemokine CXCL10
  • Chemokines, CXC / physiology
  • Dendritic Cells / drug effects*
  • Down-Regulation / drug effects
  • Endotoxins / pharmacology
  • Gene Expression Regulation / drug effects*
  • Humans
  • Interferon Inducers / pharmacology*
  • Interferon alpha-2
  • Interferon-alpha / pharmacology*
  • Interferon-beta / pharmacology*
  • Membrane Proteins / biosynthesis*
  • Membrane Proteins / genetics
  • Monocytes / cytology
  • Poly I-C / pharmacology
  • Receptor, Interferon alpha-beta
  • Receptors, Interferon / biosynthesis*
  • Receptors, Interferon / genetics
  • Recombinant Proteins / pharmacology
  • STAT1 Transcription Factor / physiology
  • STAT2 Transcription Factor / physiology
  • Transcription, Genetic

Substances

  • Antibodies, Monoclonal
  • CXCL10 protein, human
  • Chemokine CXCL10
  • Chemokines, CXC
  • Endotoxins
  • IFNAR1 protein, human
  • IFNAR2 protein, human
  • Interferon Inducers
  • Interferon alpha-2
  • Interferon-alpha
  • Membrane Proteins
  • Receptors, Interferon
  • Recombinant Proteins
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • STAT2 Transcription Factor
  • STAT2 protein, human
  • Receptor, Interferon alpha-beta
  • endotoxin, Escherichia coli
  • Interferon-beta
  • Poly I-C